Key facts
- It has raised $1.3M; the latest was Accelerator/Incubator in Apr 2025.
- Notable investors include DFF Ventures, Dinko Valerio, Google Accelerator, James Shannon, Jeroen Tas — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for EvidenceHunt
- ·The full record, as it builds
Funding rounds
No funding rounds for EvidenceHunt are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EvidenceHunt
Developer of an AI-powered research platform designed to make research simple and reliable for individuals and teams at universities. The company specializes in streamlining the process of gathering, analyzing, and utilizing medical evidence, enabling users to get an interactive chat box and direct search for quick, reliable medical insights.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2023
- Employees
- 14
- Website
- evidencehunt.com/
- Ownership
- Privately Held (backing)
EvidenceHunt doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EvidenceHunt shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EvidenceHunt in its N-PORT filings yet. We sweep new filings monthly.